Integramed America, Inc. (INMD) Misses Q2 EPS by 10c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- S&P 500, Nasdaq advance as oil eases ahead of Fed decision
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Deutsche Bank’s Reid sees potential final dip this year before Santa rally
- UPS tops estimates as efficiency drive gains momentum
- GM to move stock listing to Nasdaq in November, shares gain
Tweet
Share
E-mailGet Alerts INMD Hot Sheet
Price: $13.61 -0.8%
Revenue Growth %: -1.7%
Financial Fact:
Cost of services and sales: 46.99M
Today's EPS Names:
OMID, SICP, SCKT, More
Revenue Growth %: -1.7%
Financial Fact:
Cost of services and sales: 46.99M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Integramed America, Inc. (NASDAQ: INMD) reported Q2 EPS of $0.04, $0.10 worse than the analyst estimate of $0.14. Revenue for the quarter came in at $76.19 million versus the consensus estimate of $76.05 million.
For earnings history and earnings-related data on Integramed America, Inc. (INMD) click here.
For earnings history and earnings-related data on Integramed America, Inc. (INMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta's $97.5B AI money grab: why Zuckerberg is racing to raise cash before rivals
- Analyst explains why optical stocks are moving higher
- Cipher Digital rises as AI data center rebuttal lifts sector
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
